Researchers have identified an enzyme which protects cells from making errors during cell division by ensuring chromosomes are properly segregated . The enzyme’s activity was found to be compromise...
Read moreSe ha trabajado en la creación de un sistema de palpación de la próstata que transforma en objetiva, reproducible y útil la información recogida durante la exploración. El dispositivo permite ge...
Read moreTo generate the new models a fresh biopsy of the original tumor was implanted into the same mouse tissue. This perfectly reproduces the original morphological and molecular characteristics, and theref...
Read moreSe ha descrito el papel esencial de la temporalización de las distintas terapias en cáncer, especialmente a lo largo del ciclo dia/noche, y su relación con eficacia.
Read moreIRB Barcelona researchers publish guidelines for the design of new molecules with pharmacological potential for the treatment of a wide range of diseases, including prostate cancer.
Read moreResearchers at IRB Barcelona and the Institut Curie describe a new phenomenon of functional instability called “Illuminati”. Published in the scientific journal Development, this is an epigenetic ...
Read moreEl Hospital Germans Trias ha establecido, por primera vez en Catalunya, un circuito asistencial para tratar, con una nueva terapia poco invasiva y de forma ambulatoria, a aquellos pacientes que tras r...
Read moreEl Instituto de Investigación Sanitaria INCLIVA participa en un ensayo clínico internacional, denominado ABIGAIL, que comparará la eficacia de abemaciclib en combinación con terapia endocrina (let...
Read moreAn international study in which researchers from the Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau and the Universitat Autònoma de Barcelona (UAB) have participated ...
Read moreFindings show that camizestrant, an oral next generation selective estrogen receptor degrader (ngSERD), significantly improves progression-free survival versus fulvestrant in patients with estrogen re...
Read moreUno de los subtipos más comunes de melanoma es causado por mutaciones en NRAS, una proteína relacionada con la malignidad de las células que se halla alterado en un 25% de los casos. Su tratamiento...
Read moreOryzon Genomics presents the final data from its Phase IIa ALICE trial, investigating iadademstat in combination with azacitidine in elderly or unfit patients with acute myeloid leukemia (AML), at the...
Read more